Cost major barrier to NIPT use, say physicians

Article

Changes to practice guidelines and insurance coverage are needed, the authors say.

Results of a survey published in the September issue of The Journal of Maternal-Fetal & Neonatal Medicine reveal that insurance coverage is considered the biggest barrier to routine use of noninvasive prenatal testing (NIPT).

Researchers designed a questionnaire to assess ob/gyns’ knowledge of and attitudes toward screening options for aneuploidy, with a focus on NIPT. Questions evaluated current practices regarding aneuploidy screening as well as the physicians’ opinions of and experiences with NIPT.

The respondents identified NIPT as clinically superior to traditional screening methods and indicated that they would like ACOG to formally recommend NIPT for any pregnant woman. Of note, nearly 15% misunderstood NIPT as being a diagnostic test for fetal aneuploidy.

More than 81% of the respondents said they would use NIPT as a first-line screening test if patients' insurance offered full coverage.

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
March of Dimes reports increase in maternity care desert prevalence | Image Credit: marchofdimes.org.
Discussing low-dose aspirin use for preeclampsia prevention | Image Credit: komodohealth.com
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.